BDO Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$32.1K Buy
594
+402
+209% +$21K ﹤0.01% 500
2023
Q1
$9.61K Hold
192
﹤0.01% 711
2022
Q4
$8.88K Hold
192
﹤0.01% 703
2022
Q3
$7K Hold
192
﹤0.01% 768
2022
Q2
$7K Hold
192
﹤0.01% 730
2022
Q1
$9K Hold
192
﹤0.01% 748
2021
Q4
$8K Buy
192
+42
+28% +$1.76K ﹤0.01% 752
2021
Q3
$7K Hold
150
﹤0.01% 774
2021
Q2
$6K Sell
150
-289
-66% -$12.2K ﹤0.01% 832
2021
Q1
$17K Hold
439
﹤0.01% 636
2020
Q4
$16K Sell
439
-95
-18% -$3.42K ﹤0.01% 486
2020
Q3
$20K Buy
534
+95
+22% +$3.66K ﹤0.01% 421
2020
Q2
$15K Hold
439
﹤0.01% 453
2020
Q1
$14K Buy
439
+289
+193% +$11.3K ﹤0.01% 505
2019
Q4
$7K Hold
150
﹤0.01% 452
2019
Q3
$6K Hold
150
﹤0.01% 484
2019
Q2
$6K Hold
150
﹤0.01% 478
2019
Q1
$6K Hold
150
﹤0.01% 454
2018
Q4
$5K Hold
150
﹤0.01% 445
2018
Q3
$6K Hold
150
﹤0.01% 490
2018
Q2
$5K Hold
150
﹤0.01% 501
2018
Q1
$4K Sell
150
-200
-57% -$5.44K ﹤0.01% 453
2017
Q4
$9K Hold
350
﹤0.01% 340
2017
Q3
$10K Hold
350
0.01% 307
2017
Q2
$10K Buy
+350
New +$9.29K ﹤0.01% 369

Other funds holding BSX

BDO Wealth Advisors's BSX Position: Q2 2023 in Review

BDO Wealth Advisors increased its Boston Scientific (BSX) stake by 209% in Q2 2023, buying an estimated $21K and bringing the position to 594 shares worth $32.1K. The position accounts for ﹤0.01% of the portfolio, ranked #500.

BDO Wealth Advisors first reported a position in BSX in Q2 2017 and has held it in 25 quarters since. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

  • BDO Wealth Advisors held 594 shares of Boston Scientific worth $32.1K as of Q2 2023.
  • BDO Wealth Advisors bought 402 Boston Scientific shares in Q2 2023, an estimated $21K.
  • Boston Scientific made up ﹤0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #500 holding.
  • BDO Wealth Advisors first reported a position in Boston Scientific in Q2 2017 and has held it in 25 quarters since.
  • 1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.